Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
View ORCID ProfileTrevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
doi: https://doi.org/10.1101/2021.12.22.21268217
Trevor L. Schell
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDKeith L. Knutson
αDepartment of Immunology, Mayo Clinic Jacksonville, Florida, United States
PhDSumona Saha
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MD, MSArnold Wald
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDHiep S Phan
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMazen Almasry
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MBBSKelly Chun
γLabCorp, R&D and Specialty Medicine
PhDIan Grimes
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMegan Lutz
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMary S. Hayney
‡School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, United States
PharmD, MPHFrancis A. Farraye
†Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States
MD, MScFreddy Caldera
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
DO, MSData Availability
All data produced in the present work are contained in the manuscript.
Posted December 27, 2021.
Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Trevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
medRxiv 2021.12.22.21268217; doi: https://doi.org/10.1101/2021.12.22.21268217
Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Trevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
medRxiv 2021.12.22.21268217; doi: https://doi.org/10.1101/2021.12.22.21268217
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12609)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4479)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1058)
- Hematology (378)
- HIV/AIDS (908)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4240)
- Nursing (227)
- Nutrition (620)
- Oncology (2223)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (486)
- Public and Global Health (6826)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)